Pinpointing a tell-tale mark of liver cancer
Persistent hepatitis C virus (HCV) infection can lead to chronic hepatitis C and then progress to fatal liver diseases including liver cirrhosis and liver cancer, the third most common cause of...
View ArticleHepatitis C is transmitted by unprotected sex between HIV-infected men
Sexual transmission of hepatitis C virus (HCV) is considered rare. But a new study by researchers at Mount Sinai School of Medicine, working with the Centers for Disease Control and Prevention (CDC),...
View ArticleDanger signal limits Hepatitis C infection
Despite the fact that hepatitis C virus (HCV) persists chronically in about 80 percent of those infected, some liver cells remain free of the virus even after many years. Now Sung Key Jang of Pohang...
View ArticleStudy finds liver cancer increasing in low risk countries, decreasing in high...
A new study finds liver cancer incidence rates continue to increase in some low-risk parts of the world such as North America, and are decreasing in some of the highest risk countries of Asia. Despite...
View ArticleResearchers identify potential new therapy approach for hepatitis C
Researchers at the University of British Columbia have found a new way to block infection from the hepatitis C virus (HCV) in the liver that could lead to new therapies for those affected by this and...
View ArticleTreating chronic hepatitis C with milk thistle extract does not appear...
Use of the botanical product silymarin, an extract of milk thistle that is commonly used by some patients with chronic liver disease, did not provide greater benefit than placebo for patients with...
View ArticleHepatitis C may increase deaths from both liver-related and other diseases
[EMBARGOED FOR JULY 18, 2012] In a long-term study of people infected with the hepatitis C virus (HCV), researchers found increased deaths from both liver-related and non-liver related diseases in...
View ArticleSustained virological response linked with improved survival for patients...
Among patients with chronic hepatitis C virus infection and advanced hepatic fibrosis (development of excess fibrous connective tissue), sustained virological response (SVR) to interferon-based...
View ArticleComputer modeling reveals how surprisingly potent hepatitis C drug works
A study by researchers from Los Alamos National Laboratory and a multinational team reveals how daclatasvir, a direct-acting antiviral agent in development for the treatment of hepatitis C virus (HCV),...
View ArticleNewly incarcerated have one percent acute hepatitis C prevalence
A study published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, estimates that the prevalence of acute hepatitis C virus (HCV) infection is...
View ArticleInvestigational oral regimen for hepatitis C shows promise in NIH trial
In a study of an all-oral drug regimen, a majority of volunteers with liver damage due to hepatitis C virus (HCV) infection were cured following a six-month course of therapy that combined an...
View ArticleStudy examines ways to restore immunity to chronic hepatitis C infection
The hepatitis C virus hijacks the body's immune system, leaving T cells unable to function. A new study in animal models suggests that blocking a protein that helps the virus thrive could restore...
View ArticleBetter insights into treating hepatitis C
With nearly 200 million infected people worldwide, hepatitis C virus (HCV) represents a significant public health issue. One of the most important challenges is that although the immune system seems to...
View ArticleAGA publishes tool to help GIs manage HCV patients
The American Gastroenterological Association (AGA) Clinical Decision Tool for the Screening and Evaluation of Hepatitis C (HCV) will help gastroenterologists in the early management of HCV-positive...
View ArticleResearch tackles liver transplant failure
The re-infection of transplanted livers with hepatitis C virus (HCV) – which can irreparably damage the new organ - could be halted by administering a drug which blocks the virus entering the liver,...
View ArticleMassBiologics receives orphan drug status from FDA for hepatitis C treatment
MassBiologics of the University of Massachusetts Medical School (UMMS) has received an orphan drug designation from the U.S. Food and Drug Administration (FDA) for MBL-HCV1, a monoclonal antibody...
View ArticleAntivirals for HCV improve kidney and cardiovascular diseases in diabetic...
Researchers from Taiwan reveal that antiviral therapy for hepatitis C virus (HCV) improves kidney and cardiovascular outcomes for patients with diabetes. Results of the study published in Hepatology, a...
View ArticleNewly found tactics in offense-defense struggle with hepatitis C virus
The hepatitis C virus (HCV) has a previously unrecognized tactic to outwit antiviral responses and sustain a long-term infection. It also turns out that some people are genetically equipped with a...
View ArticleStudy quantifies prevalence of chronic HCV infection
(HealthDay)—The prevalence of hepatitis C virus (HCV) infection is about 1 percent, with 2.7 million U.S. residents estimated as having chronic HCV infection, according to a study published in the...
View ArticleEASL publishes online recommendations on the management of hepatitis C
The European Association for the Study of the Liver (EASL) will this week be announcing new on-line recommendations on the management of hepatitis C (HCV) at the International Liver Congress (ILC)....
View Article
